CD24 and neoplasm: The expression of CD24 in various malignant tumors, such as breast, gastric, hepatocellular, and bladder cancers, is closely linked to tumor invasiveness, metastatic potential, and response to treatment, suggesting a pivotal role in tumor progression (Choi et al., 2009).